This section was updated on 14 December 2021.
14/12/2021 – Notice of Results
26/10/2021 – US OEM Contract
30/09/2021 – Holding(s) in Company
27/09/2021 – Director Share Purchase
23/09/2021 – Kromek receives D3S-ID contract from US federal entity
08/09/2021 – Result of AGM 2021
13/08/2021 – Notice of 2021 AGM and Publication of Annual Report
03/08/2021 – TR1 David & Monique Newlands
14/07/2021 – Kromek Final Results
14/07/2021 – New Contracts
01/07/2021 – Notice of Results
14/06/2021 – Kromek awarded c. $6m contract by DARPA to further develop its bio-threat detection system
12/05/2021 – Director Shares Purchase
11/05/2021 – Business and Trading Update
21/04/2021 – TR1 David & Monique Newlands
09/03/2021 – Kromek wins $960k contract
04/03/2021 – TR1 Herald Investment Management Limited
02/03/2021 – PDMR Dealings
01/03/2021 – Kromek results of GM
01/03/2021 – Kromek wins Medical Screening and Nuclear Security orders
15/02/2021 – Circular – 2021 General Meeting
15/02/2021 – Posting of Circular
12/02/2021 – Firm Placing, Directors’ Subscription and Open Offer to raise up to £13 million and Notice of General Meeting
04/02/2021 – Issue of Equity and Total Voting Rights
26/01/2021 – TR1 David & Monique Newlands
18/01/2021 – Equity Development Interview – Interim Results
14/01/2021 – London South East Interview – Interim Results
14/01/2021 – TR1 David & Monique Newlands
13/01/2021 – Kromek receives Innovate UK funding to advance Biological-Threat Detection solution
13/01/2021 – Kromek Interim Results
